During the past decade, University of North Carolina Women's Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina Women's Hospital" #1 collaborator was "Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation" with 1 trials as a collaborator, "North Carolina Translational and Clinical Sciences Institute" with 1 trials as a collaborator and "Society of Family Planning" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina Women's Hospital" are "Contraception" (1 trials), "High Risk Pregnancy" (1 trials), "Hypertension" (1 trials), "Myelofibrosis" (1 trials) and "Post-Polycythemia Vera Myelofibrosis" (1 trials). Many other conditions were trialed in "University of North Carolina Women's Hospital" in a lesser frequency.

Most popular intervention types in "University of North Carolina Women's Hospital" are "Drug" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FEDRATINIB" (1 trials), "LARC First Video" (1 trials), "Levonorgestrel-releasing intrauterine system" (1 trials), "Nicotinamide 1000 mg" (1 trials) and "Nicotinamide 500 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina Women's Hospital" are 4 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "University of North Carolina Women's Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of North Carolina Women's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina Women's Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".